Table II.
Univariate and multivariate Cox regression analysis of overall survival of BC patients.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Parameters | HR (95% CI) | P-value | HR (95% CI) | P-value |
| Age (≥50 vs. <50 years) | 1.031 (0.604–1.760) | 0.911 | ||
| Menopausal status (pre vs. post) | 1.067 (0.625–1.822) | 0.812 | ||
| Tumor size (≥2 vs. <2 cm) | 1.117 (0.629–1.983) | 0.706 | ||
| Lymph node status (negative vs. positive) | 2.140 (1.254–3.650) | 0.005 | 1.332 (0.639–2.780) | 0.444 |
| TNM (stage I+II vs. III) | 1.623 (1.115–2.361) | 0.011 | 1.120 (0.665–1.885) | 0.671 |
| ER status (negative vs. positive) | 0.993 (0.577–1.708) | 0.979 | ||
| PR status (negative vs. positive) | 1.100 (0.643–1.882) | 0.727 | ||
| HER2 status (negative vs. positive) | 1.265 (0.742–2.157) | 0.387 | ||
| BANCR expression (high vs. low) | 1.614 (1.353–1.989) | <0.001 | 1.585 (1.298–1.935) | <0.001 |
HR, hazard ratio; CI, confidence interval; BANCR, BRAF-regulated lncRNA 1; TNM, Tumor-Node-Metastasis; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.